Date Filed | Type | Description |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 6% stake in PagerDuty, Inc. |
02/10/2023 |
SC 13G
| Nikko Asset Management Americas, Inc. reports a 5.2% stake in Twist Bioscience Corporation |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 7% stake in 2U, Inc. |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 5% stake in Teladoc Health, Inc. |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 2.6% stake in Stratasys Ltd. |
02/10/2023 |
SC 13G
| Nikko Asset Management Americas, Inc. reports a 6.2% stake in Roku, Inc. |
02/10/2023 |
SC 13G
| Nikko Asset Management Americas, Inc. reports a 5.8% stake in UiPath, Inc. |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 5.1% stake in CRISPR Therapeutics AG |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 0% stake in Compugen, Ltd. |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 6.3% stake in Pacific Biosciences of California, Inc. |
02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 7.1% stake in Invitae Corporation |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 5.2% stake in Organovo Holdings, Inc. |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 4% stake in Cerus Corporation |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 6.8% stake in Blade Air Mobility, Inc. |
02/10/2023 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 5.4% stake in Arcturus Therapeutics Holdings Inc |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 4.4% stake in Veracyte, Inc. |
02/14/2022 |
SC 13G
| Nikko Asset Management Americas, Inc. reports a 5.5% stake in Teladoc Health, Inc. |
02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 6.9% stake in Stratasys Ltd. |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 0.9% stake in Seres Therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 3.3% stake in Proto Labs, Inc. |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 7.2% stake in PagerDuty, Inc. |
02/14/2022 |
SC 13G
| Nikko Asset Management Americas, Inc. reports a 5.4% stake in Pacific Biosciences of California, Inc. |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 5.5% stake in Organovo Holdings, Inc. |
02/14/2022 |
SC 13G
| Nikko Asset Management Americas, Inc. reports a 6.3% stake in NIU Technologies |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 4.9% stake in Materialise NV |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 0% stake in Lending Tree, Inc. |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 8.4% stake in Invitae Corporation |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 3.7% stake in Intellia Therapeutics, Inc. |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 0% stake in The ExOne Company |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 3.9% stake in Editas Medicine, Inc. |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 5.6% stake in CRISPR Therapeutics AG |
02/14/2022 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 8.3% stake in Compugen, Ltd. |
|